|
The
calcitonin [125I] IRMA system provides a direct quantitative
determination of human calcitonin in human serum. Calcitonin can be
assayed in the range of 0-2000 pg/ml using 200 µl serum samples. Each
kit contains materials sufficient for 50 assay tubes permitting the
construction of one standard curve and the assay of 16 unknowns in
duplicate.
Introduction
Calcitonin (MW
3.4 kDa) is primarily secreted by the parafollicular C-cells of the
thyroid gland. The mature peptide hormone comprises 32 amino acid
residues. Calcitonin exerts its biological effect by acting on its
target organs: bone, kidney and the gastrointestinal tract. The
physiological role of calcitonin in bone metabolism is not fully
understood and is still under investigation. It is well established that
abnormally elevated levels of Calcitonin are characteristic of thyroid
C-cell hyperplasia and medullary thyroid carcinoma (MTC). MTC represents
5-10% of all thyroid cancer and exists in either familial or sporadic
form. Calcitonin IRMA is recommended for diagnosis and follow up of MTC
and for diagnosis of preclinical cases of the familial forms of MTC. The
circulating concentrations of calcitonin are low, normal values are less
then 15 pg/ml, and 10 pg/ml, for males and females, respectively.
In the blood
the apparent calcitonin-like immunoreactivity is contributed by various
calcitonin-related species, including the monomeric, dimeric and
polymeric forms, as well as fragments and precursors of the parent
hormone.
Principle of method
The technology
uses a high affinity monoclonal and polyclonal antibodies in an
immunoradiometric assay (IRMA) system. It offers an increased level of
sensitivity and specificity compared with conventional RIA methods.
The 125I
labelled signal-antibody binds to an epitope of the calcitonin molecule
which is different from that recognised by the unlabelled
capture-antibody. In the first step, the signal antibodies react with
the antigen present in standards or samples after which, in the second
step, the reaction with the capture antibody leads to the formation of a
capture antibody - antigen - signal antibody complex, also referred to
as a “sandwich”.
Standards and
samples are incubated with the signal antibodies at 2-8 °C temperature.
At the end of an overnight incubation period, capture antibodies are
pipetted into the reaction mixture with a two hours incubation time at
room temperature. Afterwards, magnetic immunosorbent (MIS) is added in
excess. MIS particles bind the calcitonin—signal antibody—-capture
antibody complex selectively and settle out in a magnetic field. A wash
step is critical to reducing non-specific binding to a minimum for
increased low end precision.
The
concentration of antigen is directly proportional to the radioactivity
measured in test tubes. By constructing a calibration curve plotting
binding values against a series of calibrators containing known amount
of calcitonin, the unknown concentration of calcitonin in patient
samples can determined.
Contents of the kit
|
1 bottle |
TRACER, ready to use.
21 ml, containing about 740 kBq 125I-anti-calcitonin
and capture anti-calcitonin in buffer with red dye and 0.1% NaN3. |
|
1
vial |
ANTISERUM, ready to use.
2.7 ml, containing capture-anti-calcitonin in buffer with blue
dye and 0.1% NaN3. |
|
6
vials |
STANDARD
6 x 1 ml, lyophilized in serum with 0.1% NaN3.
The exact concentrations are indicated on each vial. See
Preparation of reagents
(Calibrated against 2nd International Standard, code
89/620.) |
|
1 vial |
CONTROL SERUM.
Lyophilized human serum with 0.1% NaN3.
The concentrations of control serum is specified in the quality
certificate enclosed.
See Preparation of reagents |
|
1
bottle |
MAGNETIC IMMUNOSORBENT (MIS), ready to use.
55 ml, containing paramagnetic particles in buffer with 0.1% NaN3. |
|
1 bottle |
WASH BUFFER CONCENTRATE.
20 ml, containing 0.1% NaN3. See Preparation of
reagents |
|
1 pc |
Quality certificate |
|
1 pc |
Pack
leaflet |
Materials, tools and equipment required
Test tube rack
Precision pipettes with disposable tip (50, 100, 200, and 1000
µl)
Distilled water
Vortex mixer
Shaker
Plastic foil
Gamma counter
Absorbent tissue
Recommended
tools and equipment
Repeating pipettes (e.g. Eppendorf)
Dispenser with 300 ml reservoir (instead of the 2 ml pipette)
Specimen collection and storage
Serum
samples can be prepared according to common procedures used routinely in
clinical laboratory practice. Samples can be stored at 2-8 °C if the
assay is carried out within 24 hours, otherwise aliquots should be
prepared and stored deep frozen (-20 °C). Frozen samples should be
thawed and thoroughly mixed before assaying. Repeated freezing and
thawing should be avoided. Do not use lipemic, hemolyzed or turbid
specimens. Samples with a calcitonin concentration higher than that of
the most concentrated standard should be diluted and reassayed.
Preparation of reagents, storage
Add the
wash buffer concentrate (20 ml) to 200 ml distilled water to obtain 220
ml wash solution. Upon dilution store at 2-8 °C until expiry date.
Add
1000 µl distilled water to the standards and lyophilized control serum.
Mix gently with shaking or vortexing (foaming should be avoided).
Ensure
that complete dissolution is achieved, and allow the solution to
equilibrate at room temperature for at least 20 minutes. Store at -20 °C
until expiry date.
Store
the rest of reagents between 2-8 °C after opening. At this temperature
each reagent is stable until expiry date. The actual expiry date is
given on the package label and in the quality certificate.
CAUTION! Equilibrate all reagents and serum samples to room temperature.
Mix all reagents and samples thoroughly before use. Avoid excessive
foaming.
Assay procedure
(For a quick guide, refer to Table 1.)
|
1 |
Equilibrate reagents and samples to room temperature before use. |
|
2 |
Label tubes in duplicate for total counts (T), each
standard (S0-S5), control serums and samples.
|
|
3 |
Homogenize all reagents and samples by gentle mixing to avoid
foaming. |
|
4 |
Pipette 200 µl of standards, controls and samples into the
properly labelled tubes. Use rack to hold the tubes. |
|
5 |
Pipette 100 µl of tracer into each tube. |
|
6 |
Thoroughly vortex mix all tubes except T for 2-5 seconds. When
having an orbital shaker, leave all tubes in the rack holder,
fix the holder onto the plate of the shaker, and shake it gently
for a few seconds. |
|
7 |
Incubate tubes overnight at 2-8 °C. |
|
8 |
Pipette 50 µl of antiserum solution into all tubes except T.
|
|
9 |
Thoroughly vortex mix all tubes except T for 2-5 seconds. When
having an orbital shaker, leave all tubes in the rack holder,
fix the holder onto the plate of the shaker, and shake it gently
for a few seconds. |
|
10 |
Cover
tubes with a plastic foil, and allow them to incubate for 2
hours at room temperature. |
|
11 |
Place
T tubes on a separate tube rack. Gently shake and swirl the
bottle containing magnetic immunosorbent until homogeneity is
achieved. Add 1000 µl MIS to each tube except T. When using a
single pipette, swirl the bottle of MIS after every 15-20 tubes.
With the use of a repeating pipette (e.g. Eppendorf), there is
no need for repeated homogenisation of MIS reagent.
|
|
12 |
Thoroughly vortex mix all tubes, and incubate them for 15
minutes at room temperature. |
|
13 |
Attach
the rack on to the magnetic separator base and ensure that every
tube is in contact with the base plate. Let the MIS particles
settle for 5 minutes. Do not remove the rack from the separator
base after the separation of the solid and liquid phases. Pour
off and discard the supernatant. Keeping the separator inverted,
place the tubes on a pad of absorbent tissue and allow to drain
for 2 minutes. |
|
14 |
Return
the separator to an upright position and add 1.0 ml of washing
solution to each tube. For more comfort and precision, it is
recommended to use either a repeating pipette (e.g. Eppendorf
pipette) or a dispenser with bottle for the addition of washing
solution. |
|
15 |
Vortex mix each tube thoroughly and repeat Step 10.
Intense vortexing is required when working with a singular
pipette, but repipettors will inject the washing solution
efficiently enough to have the pellett resuspended even without
a subsequent vortexing step. |
|
16 |
Count
each tube for at least 60 seconds in a gamma counter. |
|
17 |
Calculate the concentrations of the samples as described in
Calculation of results. |
Table 1.
Assay Protocol, Pipetting Guide (all volumes in microliters)
|
Tubes |
Total |
Standard |
Sample |
Control |
|
Standard |
|
200 |
|
|
|
Sample |
|
|
200 |
|
|
Control |
|
|
|
200 |
|
Tracer |
100 |
100 |
100 |
100 |
|
Vortex, incubate overnight at 2-8 °C |
|
Antiserum |
|
50 |
50 |
50 |
|
Vortex, incubate for 2 hours at room temperature |
|
Magnetic immunosorbent |
|
1000 |
1000 |
1000 |
|
Vortex, incubate for 15 minutes at room temperature |
|
Separate for 5 minutes |
|
Decant the fluid and blot on filter paper |
|
Wash
Buffer |
|
1000 |
1000 |
1000 |
|
Separate for 5 minutes |
|
Decant the fluid and blot on filter paper |
|
Count radioactivity (60 sec/tube) |
|
Calculate the results |
Table 2.
Typical Assay Data
| |
cpm
1 |
cpm
2 |
cpm
mean |
B/T % |
|
Total |
314048 |
311803 |
312926 |
- |
|
S0 |
148 |
213 |
181 |
0.058 |
|
S1 |
1205 |
1311 |
1258 |
0.402 |
|
S2 |
3886 |
3955 |
3921 |
1.253 |
|
S3 |
14347 |
14485 |
14416 |
4.607 |
|
S4 |
43195 |
42999 |
43097 |
13.77 |
|
S5 |
116140 |
114027 |
115084 |
36.77 |
|
C-I |
1890 |
1843 |
1867 |
0.596 |
|
C-II |
10111 |
9833 |
9972 |
3.187 |
Figure 1
A typical standard curve
(Do not use to calculate unknown samples)
Calculation of results
The
calculation is illustrated using representative data. Data obtained
should be similar to those shown in Table 2.
Calculate the average CPM for each pair of assay tubes. Calculate the
normalized percent binding for each standard, control and sample
respectively by using the following equation:
|
B/T (%) = |
S1-5 [C, Mx] (cpm) – S0
(cpm) |
x 100 |
|
——————————— |
|
T (cpm) |
Using
semi-logarithmic graph paper plot B/T (%) for each standard versus the
corresponding concentration of calcitonin.
Determine the
calcitonin concentration of the unknown samples by interpolation from
the standard curve. Do not extrapolate values beyond the standard curve
range.
Out of fitting
programs applied for computerized data processing logit-log, or spline
fittings can be used. Automated data processing systems are also
available.
Characterization of the assay
Assay
parameters
|
NSB/T |
< 0.1
% |
|
Bmax/B0 |
> 400 |
Sensitivity
A detection
limit of 2 pg/ml has been obtained by assaying 20 replicates of the zero
standard. The sensitivity is defined as the concentration corresponding
to the sum of the mean cpm and its double standard deviation.
Hook effect
There
is no high dose "hook effect" up to a calcitonin concentration of 100000
pg/ml.
Specificity
The
monoclonal and the polyclonal antibodies used in this IRMA kit are
specific for hcalcitonin. No cross reactivity with eel, salmon, porcine
and eel analogue calcitonin can be detected up to 200000 pg/ml
concentrations.
Precision
4
patient samples were assayed in 15 replicates to determine intra-assay
precision. Values obtained are shown below.
|
Sample |
Number of replicates |
Mean value |
SD |
CV
% |
|
1 |
15 |
799.6 |
16.8 |
2.1 |
|
2 |
15 |
321.3 |
4.5 |
1.4 |
|
3 |
15 |
83.8 |
2.0 |
2.4 |
|
4 |
15 |
21.5 |
0.9 |
4.4 |
Reproducibility
To
determine inter-assay precision 4 patient samples were measured in
duplicates in 20 independent assays by 2 operators using different kit
batches. Values obtained are shown below.
|
Sample |
Number of runs |
Mean value |
SD |
CV
% |
|
1 |
20 |
791 |
18.2 |
2.3 |
|
2 |
20 |
326 |
7.2 |
2.2 |
|
3 |
20 |
83 |
2.7 |
3.3 |
|
4 |
20 |
21 |
1.0 |
4.7 |
Recovery
Recovery was
defined as the measured increase expressed as percent of expected
increase upon spiking serum samples with known amount of hcalcitonin.The
average percent recovery for 4 serum pools spiked with calcitonin at 3
levels was: 93.0 ± 9.9 (mean ± SD).
Expected
values
Healthy
adults: 0 - 10 pg/ml
It is
recommended that each laboratory determine a reference range for its own
patient population.
Procedural notes
Addition of wash buffer. For the addition of wash
buffer the use of a common laboratory dispenser equipped with a 300 ml
glass bottle, and a flexible outlet tubing end is recommended. In lack
of this tool a large volume syringe attached to a repeating pipette can
be used.
Additional information
Components
from various lots or from kits of different manufacturers should not be
mixed or interchanged.
Precaution
Radioactivity
This product
contains radioactive material. It is the responsibility of the user to
ensure that local regulations or code of practice related to the
handling of radioactive materials are satisfied.
Biohazard
Human blood
products used in the kit have been obtained from healthy human donors.
They were tested individually by using approved methods (EIA, enzyme
immunoassay), and were found to be negative, for the presence of both
Human Immunodeficiency Virus antibody (Anti-HIV-1) and Hepatitis B
surface Antigen (HBsAg).
Care should
always be taken when handling human specimens to be tested with
diagnostic kits. Even if the subject has been tested, no method can
offer complete assurance that Hepatitis B Virus, Human Immunodeficiency
Virus (HIV-1), or other infectious agents are absent. Human blood
samples should therefore be handled as potentially infectious
materials.
Chemical
hazard
Components
contain sodium azide as an antimicrobial agent. Dispose of waste by
flushing with copious amount of water to avoid build-up of explosive
metallic azides in copper and lead plumbing. The total azide present in
each pack is 74 mg.
 |
Use by |
 |
In vitro diagnostic medical device |
 |
Control |
 |
Batch code |
 |
Manufacturer |
 |
Standard |
 |
Caution, consult accompanying documents |
 |
Radioactive material |
 |
Magnetic immunosorbent |
 |
Biological risk |
 |
Temperature limitation
Store between 2-8 °C |
 |
Tracer |
 |
Consult instructions for use |
 |
Catalogue number |
 |
Wash buffer |
| |
|
 |
Serum diluent |
 |
Antiserum |
Calcitonin IRMA test

|